Abstract
Case description A 85 year old woman with a history of severe depression treated with mirtazapine and venlafaxine was admitted to the hospital twice after progressive deterioration of her general condition evolving to unconsciousness. Clinicians diagnosed a metabolic encephalopathy caused by a urinary tract infection which was treated appropriately. Although mirtazapine was stopped during the first hospitalization, the patient’s general practitioner restarted mirtazapine four days before readmission. During rehospitalization, she developed extreme restlessness, hyperreflexia and an increased tone in the lower limbs. She was hypertensive and tachycardic. Excessive sweating, elevated creatine kinase levels and bilateral mydriasis were noticed. Urinary analysis showed positive levels of mirtazapine and venlafaxine and both drugs were withdrawn. Symptoms resolved within 48 h after discontinuation of her antidepressants. Conclusion To our knowledge, this is the first case of the serotonin syndrome confirmed by a positive challenge, de-challenge and re-challenge.
References
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–20.
Dunkley EJ, Isbister GK. The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(635):642.
Mason PJ, Morris VA, Balcezak TJ. Serotonin Syndrome: presentation of two cases and review of the literature. Medicine (Baltimore). 2000;79:201–9.
Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract. 1999;49:871–4.
Poeshla BD, Bartle P, Hansen KP. Serotonin syndrome associated with polypharmacy in the elderly. Gen Hosp Psychiatry. 2011;33(3):301.e9–11.
Dimellis D. Serotonin syndrome produced by a combination of venlafaxine and mirtazapine. World J Biol Psychiatry. 2002;3:167. Letter.
Houlihan DJ. Serotonin syndrome resulting from coadministration of tramadol, venlafaxine and mirtazapine. Ann pharmacotherapy. 2004;38:411–3.
Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotoninsyndrome: review. J Clin Psychopharmacol. 1997;17(3):208–21.
Gillman PK. Serotonin syndrome: history and risk. Fundam Clin Pharmacol. 1998;12(5):482–91.
Sato S, Yokota C, Toyoda K, Naganima M, Minematsu K. Hyperammonemic encephalopathy caused by urinary tract infection with urinary retention. Eur J Intern Med. 2008;19:e78–9.
Funding
None.
Conflicts of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Decoutere, L., De Winter, S., Vander Weyden, L. et al. A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge. Int J Clin Pharm 34, 686–688 (2012). https://doi.org/10.1007/s11096-012-9666-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-012-9666-7